Oncology & Cancer

Study may explain why once-promising cancer drugs failed

Nearly two decades after a class of once-promising cancer drugs called MMP inhibitors mysteriously failed in clinical trials, scientists think they may have an explanation for what went wrong.

Oncology & Cancer

Pushing closer to a new cancer-fighting strategy

A molecular pathway that's frequently mutated in many different forms of cancer becomes active when cells push parts of their membranes outward into bulging protrusions, Johns Hopkins researchers report in a new study. The ...

page 18 from 40